Wyeth obtains U.S. approval for Premarin's expanded use

11/13/2008 | Forbes

The FDA is allowing Wyeth to market its Premarin cream to treat dyspareunia, or painful sexual intercourse, in postmenopausal women. The approval covers twice-weekly doses of the hormone-replacement drug, which is already sold as a treatment for hot flashes, vaginal dryness and other symptoms of menopause.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ